Arbutus presents new data on ab-729, ab-836 and ab-101 at the easl international liver congress™ 2022 and provides ab-836 clinical update

Ab-729, our rnai therapeutic, provided robust and comparable hbsag declines in both hbeag+ and hbeag- patients

ABUS Ratings Summary

ABUS Quant Ranking